1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)COVID-19, Coronaviridae Infections, Infections, Inflammation, Mononegavirales infectious disease, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Paramyxoviridae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Pneumovirus Infections, RNA Virus Infections, Respiration Disorders, Shock, Systemic Inflammatory Response Syndrome, adult acute respiratory distress syndrome, cytokine release syndrome, influenza, lung disorder, pneumonia, respiratory syncytial virus infectious disease, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumoniaRecruitingPhase 1 / Phase 22026-06-10NCT06684379